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Migration to industrialised countries poses a “double whammy” for type 2 diabetes among sub-Saharan African 
migrant and refugee adults. This population group has been found to be at an increased risk of obesity and type 2 
diabetes, which may be further aggravated by inadequate vitamin D status. Thus, this study aimed to describe the 
demographics of vitamin D insufficiency, obesity, and risk factors for type 2 diabetes among sub-Saharan Afri-
can migrants and refugees aged 20 years or older living in Melbourne, Australia (n=49). Data were obtained by a 
questionnaire, medical assessment, and fasting blood samples. The mean serum 25-hydroxyvitamin D level was 
27.3 nmol/L (95% CI: 22.2, 32.4 nmol/L); with 25-hydroxyvitamin D levels <50 nmol/L occurring in 88% of 
participants. Participants displayed a cluster of risk factors for type 2 diabetes and cardiovascular disease: 62% 
were overweight or obese, 47% had insulin resistance (HOMA-IR ≥2), 25% had low density lipoprotein choles-
terol levels ≥3.5 mmol/L, 24.5% had high density lipoprotein cholesterol levels ≤1.03 mmol/L, 34.6% had bor-
derline or high levels of total cholesterol (≥5.2 mmol/L), 18.2% had borderline or high levels of triglyceride 
(≥1.7 mmol/L), and 16% had hypertension (systolic blood pressure ≥140 mmHg or diastolic blood pressure ≥90 
mmHg). These findings suggest that sub-Saharan African migrants and refugees may be at risk of type 2 diabetes 
and atherosclerosis-related diseases such as ischemic heart disease, stroke, and peripheral vascular disease. Well-
designed vitamin D interventions that incorporate lifestyle changes are urgently needed in this sub-population. 
 
Key Words: vitamin D insufficiency, fasting plasma glucose, African migrants and refugees, insulin resis-
tance, obesity 
 
 
 
INTRODUCTION 
The number of Sub-Saharan African (SSA) migrants and 
refugees relocating to high income countries such as Aus-
tralia, Western Europe, Canada, and the United States of 
America has been increasing over the last two decades.1-5 
Upon arrival in their host countries, SSA migrants and 
refugees have been found to be at increased risk of obe-
sity and type 2 diabetes (T2D).6-10 This increased risk of 
obesity and T2D rises further with longer length of re-
settlement, peaking within 5-10 years after migration. 
Obesity is known to be a major risk factor for T2D, both 
total-body and central abdominal obesity are strongly 
related to insulin resistance, a precursor of T2D.11,12 
However, for SSA migrants and refugees the risk of T2D 
could be further aggravated by vitamin D insufficiency 
(VDI).13 Australian and overseas studies have found that 
SSA migrants are at increased of VDI following migra-
tion to industrialised countries.14-17 These studies have 
found that VDI is associated with Muslim religion, 
younger age, female gender, longer length of stay in the 
host country, covering clothing, decreased daylight expo-
sure, and testing vitamin D levels during winter or spring. 
Available evidence suggest that VDI is a risk factor for 
the metabolic syndrome, which is characterised by a clus-
tering of hyperglycaemia, abdominal obesity, dyslipidae-
mia, and hypertension.18 It has been noted that 25-  
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hydroxyvitamin D (25-OHD) is negatively correlated 
with fasting plasma glucose, fasting insulin, and insulin 
resistance.13,19 
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These findings indicate that VDI is a risk factor for the 
metabolic syndrome and suggest that understanding the 
role of VDI in the cardiovascular health burden should be 
a priority to assess whether lower levels of serum 25-
OHD among SSA migrants and refugees predisposes 
them to the metabolic syndrome. However, before such a 
study takes place, an inventory of the components of the 
metabolic syndrome among this sub-population must first 
be established. Therefore, the purpose of this study was to 
describe the demographics of VDI, obesity, and risks of 
T2D, among SSA migrants and refugees in the western 
metropolitan region of Melbourne, Australia. 
 
MATERIALS AND METHODS 
Participants and recruitment 
Study participants were newly arrived SAA migrants and 
refugees, aged ≥20 years, who had not taken any vitamin 
D supplements in the two years prior to the study. The 
study targeted local government areas in the western met-
ropolitan region of Melbourne (Wyndham, Maribyrnong, 
Moonee Valley, and Brimbank), where the number Afri-
can migrants and refugees is estimated to be about 21,720 
people.1 Participants were recruited by collaborating with 
the staff of three community and health centres who 
helped to promote the study, and the study was advertised 
via 60 posters that were displayed in the centres and at the 
Footscray market. In addition, 220 leaflets in Arabic were 
distributed through community centres, refugee health 
programs, African community workers, women’s groups, 
the African Review Panel (ARP), and general medical 
practices. The project was publicised in the Star News 
Group, complemented by a SBS radio announcement in 
Arabic. All promotion of the study instructed interested 
participants to contact members of the research team (a 
contact number was provided). Fifty five participants 
responded to our call for participation and received fur-
ther information about the project through a plain lan-
guage statement. Of the 55 responding participants, 50 
consented to take part in the study. The study implemen-
tation was overseen by the African Review Panel (ARP) – 
a lay person steering committee. The ARP was established 
as part of previous research in this sub-population.6,20,21 
The study was approved by Deakin University Human 
Ethics Committee and all data were collected between 
July and November 2009 (ie over winter or spring). 
 
Procedures and study variables 
For those who consented to take part, a questionnaire was 
administered by either the research assistant or the refu-
gee health nurse to obtain demographic and socio-
economic data including: age, gender, country of origin, 
residence prior to migration, length of stay, and standard-
ized measurements of weight, height and waist and hip 
circumferences. Appointments were organised for con-
senting participants to be seen both by the medical practi-
tioner to measure blood pressure and the clinic nurse at 
Doutta Galla Community Health Services for blood col-
lection. Transport was made available for participants 
with no transportation means. 
Height (measured to the nearest 0.5 cm without shoes 
using a stadiometer) and weight (recorded to the nearest 
50g using the UC-321 scale, A&D Co Ltd, London) were 
obtained and used to compute the body mass index (BMI) 
using the following formula: weight (kg)/[height (m)]2. 
BMI was categorised to obtain the proportion of over-
weight (25.0-29.9 kgm-2) and obesity (≥30 kgm-2).22 Two 
measurements for the waist (measured to the nearest 0.5 
cm; halfway between the lower border of the ribs and the 
iliac crest in a horizontal plane) and hip (measured to the 
nearest 0.5 cm; at the widest point over the buttocks) cir-
cumference were obtained using a steel measuring tape. 
For each parameter, if the difference between the two 
parameters was greater >2 cm, a third measurement was 
taken. The mean of the two closest measurements was 
calculated. Waist-to-hip ratio (WHR) was obtained by 
dividing the waist circumference by the hip-
circumference, and categorised according to the propor-
tion of overweight (0.90-0.99 for men and 0.80-0.84 for 
women) and central obesity (WHR ≥1 for men and ≥0.85 
for women).22 
Blood pressure was measured in a seated position us-
ing a standard mercury manometer. The participant was 
instructed to rest for at least five minutes before the blood 
pressure measurement was taken. The average of two 
readings of the blood pressure was used to define hyper-
tension. Hypertension was defined as systolic blood pres-
sure (SBP) ≥140 mmHg or diastolic blood pressure (DBP) 
≥90 mmHg according to the World Health Organization 
cut-off points,23 and SBP >130 mmHg or DBP >85 
mmHg according to the International Diabetes Federation 
cut-off points.24 
Following an overnight fast between 07.00h and 
10.00h, a blood sample for glucose studies, insulin, lipid 
studies, and 25-OHD was collected with the participant in 
a seated position. All blood collections were taken by a 
trained nurse in collaboration with Melbourne Pathology. 
Specimens were analysed as received in the laboratory, 
within 12 hours of collection. All samples were analysed 
by Melbourne Pathology service using Roche/Hitachi 
Modular® E170 for insulin; Roche/Hitachi Modular® 
System P for C-reactive protein (CRP), high-sensitivity 
CRP (hs-CRP), high-density lipoprotein cholesterol 
(HDL-C), and plasma glucose; Siemens Immulite for C-
peptide; and DiaSorin LIAISON® for 25-OHD. Low 
density lipoprotein cholesterol (LDL-C) was calculated 
using the Friedewald Formula.25 The Homeostasis Model 
of Assessment (HOMA) was used to evaluate insulin re-
sistance. The insulin resistance score (HOMA-IR) was 
computed using the following: fasting plasma glucose 
(mmol/L) multiplied by fasting serum insulin (mU/L) 
divided by 22.5.26 
Vitamin D insufficiency was defined as serum 25-
OHD <50 nmol/L.15 A HOMA-IR cut-off point was used 
to determine high insulin sensitivity (HOMA-IR <1.93) 
and low insulin sensitivity/ insulin resistance (HOMA-IR 
≥1.93).26 Fasting plasma glucose abnormalities were ca-
tegorized according to the 1998 World Health Organiza-
tion criteria (normal plasma glucose <6.1 mmol/L, im-
paired fasting glycaemia 6.1-6.9 mmol/L, and diabetes 
≥7.0 mmol/L).27 Lipids were classified as abnormal using 
the following cut-off points: total cholesterol >5.2 
mmol/L; LDL-C >3.4 mmol/L; triglyceride >1.7 mmol/L; 
and HDL-C <1.03 mmol/L.28 
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Data analysis 
All data were analysed using Stata 10.0. (Stata Statistical 
Software, College Station TX). Given the exploratory 
nature of the study, data were summarised using descrip-
tive statistics. 
 
RESULTS 
Fifty African migrants or refugees participated in the 
study; however one participant was excluded due to an 
incomplete data set. All subsequent analysis refer to the 
final sample of 49 participants (29 men, 20 women). The 
mean age of the participants was 41.5 years (men: 43.0 
years, 95% CI: 37.0-48.9; women: 39.5 years, 95% CI: 
33.7-45.2). The participants were relatively new arrivals, 
with an average length of stay of 6 years (men: 5.7 years, 
95% CI: 3.8-7.6 years; women: 6.3 years, 95% CI: 3.3-
9.4 years). Participants were predominantly from Ethiopia 
(39%), Sudan (22%) and Eritrea (20%) and Somalia 
(10%). The remaining 8% included migrants from Congo, 
Ghana, Rwanda and Nigeria. The reasons for migration 
included refugee’s status (48%), family reunion (40%), 
political/asylum seekers (10%) and educational opportu-
nities (2%).  
Table 1 summarises data on vitamin D status, anthro-
pometric outcomes, blood pressure, and high sensitivity 
CRP. The table shows data collected in the present study 
in the ‘African refugees and migrants’ column and a 
comparison point to other Australian data (when avail-
able), from the AusDiab study.40,45,46 The prevalence of 
vitamin D insufficiency (25-OHD levels <50 nmol/L) was 
82.8% among males and 95.0% among females. The pre-
valence of VDI did not vary by gender, age, or length of 
stay. Based on BMI cut-off points, 85.7% of women and 
44.8% of men were overweight or obese. Age was posi-
tively correlated with BMI (r=0.29, p=0.043) and WHR 
(r=0.41, p=0.003). However, length stay was neither as-
sociated with BMI nor WHR. The prevalence of hyper-
tension was 16% using the World Health Organization 
cut-off points, and 32% using the International Federation 
for Diabetes cut-off points. Systolic and diastolic blood 
pressure did not vary by gender. However, both systolic 
(r=0.48, p<0.001) and diastolic (r=0.38, p<0.01) blood 
pressure were positively correlated with age. Similarly, 
 
 
Table 1. Obesity, VDI, lipid profile and glucose by gender 
 
African refugees and migrants Australian data 
Variables Female 
N=20 
Male 
N=29 
All 
N=49 p value Female Male Reference
Anthropometric parameters        
Prevalence of obesity (BMI Categories)        
Healthy: % 14.3 55.2 38.0  - -  
Overweight: % 57.1 34.5 44.0 0.011 29.9 48.2 40 
Obese: % 28.6 10.3 18.0  22.2 19.3 40 
BMI kgm-2: mean (SD) 25.0 (4.6) 28.7 (5.8) 26.6 (5.4) 0.007 26.4 27.0 45 
Prevalence of  central obesity (WHR)        
Healthy: % 33.3 51.7 44.0  - -  
Overweight: % 14.3 37.9 28.0 0.004 - -  
Obese: % 52.4 10.3 28.0  - -  
WHR: mean (SD) 0.85 (0.07) 0.90 (0.09) 0.88 (0.09) 0.013 - -  
Prevalence 25–OHD (vitamin D) levels        
<50 nmol/L 95.0 82.8 87.8  39 22 46 
≥50-<75.0 nmol/L 5.0 13.8 10.2 0.409 39 45 46 
≥75.0 nmol/L 0.0 3.5 2.0  22 33 46 
25–OHD nmol/L: mean (SD) 22.9 (12.9) 30.4 (20.2) 27.3 (17.8) 0.075 59 (23) 70 (25) 46 
Lipid studies(mmol/L): mean (SD)        
Total Cholesterol 4.9 (1.1) 4.7 (0.7) 4.8 (0.9) 0.179 - -  
LDL-C 3.0 (1.0) 2.9 (0.6) 3.0 (0.8) 0.427 - -  
HDL-C 1.4 (0.4) 1.2 (0.4) 1.3 (0.4) 0.056 1.6 (0) 1.3 (0) 45 
Triglyceride 1.2 (0.5) 1.3 (1.0) 1.3 (0.8) 0.323 1.1 (0) 1.4 (0) 45 
Glucose studies: Mean (sd)        
Serum fasting glucose (mmol/L) 4.7 (0.7) 5.3 (0.9) 5.1 (0.9) 0.011 5.2 (0) 5.5 (0) 45 
Serum insulin (IU/ml) 10.0 (7.9) 9.5 (6.2) 9.7 (6.9) 0.407 12.1 (6) 12.7 (6) 45 
HOMA-IR (Units) 2.1 (1.7) 2.3 (1.6) 2.2 (1.6) 0.355 - -  
Plasma C-Peptide (pmol/ml) 0.48 (0.23) 0.52 (0.28) 0.5 (0.3) 0.319 - -  
Blood pressure        
Systolic (mmHg): Mean (sd) 126 (21) 130 (19) 128 (20) 0.220 124(17) 131(18) 45 
Diastolic (mmHg): Mean (sd) 78 (12) 80 (12) 79 (12) 0.291 66.2(8) 74.6(12) 45 
% SBP≥140 mmHg and DBP≥90 mmHg 
(WHO) 9.5 20.7 16.0 0.288 - -  
% SBP≥135 mmHg and DBP≥85 mmHg 
(IDF) 28.6 34.5 32.0 0.658 - -  
High sensitivity CRP (hs-CRP) (mg/L): %     - -  
Low (<1.0 mg/L) 5.0 27.6 18.4  - -  
Moderate (1.0-3.0 mg/L) 40.0 51.7 46.9 0.022 - -  
High (>3.0 mg/L) 55.0 20.7 34.7  - -  
(hs-CRP) (mg/L): mean (SD) 4.1 (2.9) 2.5 (2.5) 3.2 (2.8) 0.050 - -  
400 Vitamin D insufficiency and diabetes risk factors 
 
systolic (r=0.45, p<0.01) and diastolic (r=0.46, p<0.01) 
blood pressure were positively correlated with length of 
stay. More than one in three participants (34.7%) had 
high hs-CRP values, and hs-CRP values were higher 
among women than men (p<0.05). Hs-CRP levels were 
not associated with age or length of stay. 
Figure 1 summarises data on fasting plasma glucose 
and fasting serum insulin. Figure 2 summarises data on 
lipid profile. Diabetes and insulin resistance were found 
in 2% and 46.9% of participants respectively, and did not 
differ by gender or length of stay in Australia. However, 
fasting glucose was positively associated with age 
(r=0.53, p<0.001). Hyperlipidemia was present in this 
sub-population. Length of stay was positively correlated 
with total cholesterol (r=0.33, p=0.021), LDL-C (r=0.31, 
p=0.0314), and marginally with triglyceride (r=0.25, 
p=0.078), but not associated with HDL-C. None of the 
lipid parameters were associated with age.  
 
DISCUSSION 
This is the first study in Australia to simultaneously 
measure the risk of the metabolic syndrome and cardio-
vascular disease among newly arrived migrants and refu-
gees of an SSA background. It should be noted that due to 
the voluntary nature of participation and small sample 
size, the results of this pilot study cannot be generalised 
to the wider community of SSA migrants living in Aus-
tralia. Also, given the exploratory nature of the study and 
small sample size, it was not possible to examine the rela-
tionship between vitamin D status and the risk of meta-
bolic syndrome here. Despite these limitations, this study 
identified a clustering of risk factors for the metabolic 
syndrome and a high prevalence of VDI amongst partici-
pants, suggesting that SSA migrants in Melbourne are at 
high risk of obesity, impaired glucose and VDI.  
We found that more than three quarters of the studied 
population were vitamin D insufficient. Our findings are 
consistent with those reported by Skull and colleagues.15 
Current evidence suggests that low vitamin D levels may 
increase the risk of the metabolic syndrome.29 Some of 
the many pathological disorders recently been linked with 
VDI include cancers,30,31 ischemic heart disease,32,33 im-
paired immune response,34 increased risk of adiposity, 
impaired glucose tolerance, impaired lipid metabolism, 
and elevations in blood pressure.35-38 Data from the Third 
National Health and Nutrition Examination Survey in the 
USA found that individuals in fourth quartile of serum 
25-OHD levels had higher rates of hypertension (odds 
ratio [OR], 1.30), diabetes mellitus (OR, 1.98), and obe-
 
Figure 1. Proportions of African migrant and refugee adults with high fasting glucose or insulin resistance (HOMA≥7.0mmol/L) 
 
 
Figure 2. Proportion of African migrant and refugee adults with a lipid threshold above cut-off points used to identify risk for cardiovas-
cular diseases 
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sity (OR, 2.29), and higher serum triglyceride levels (OR, 
1.47) than those in the first quartile.39 
The cardiovascular disease risk of SSA migrants and 
refugees is increased with obesity, elevated blood lipids 
and hs-CRP. Despite being relatively recent arrivals 
(mean length of stay was six years) and predominantly 
from refugee camps where under-nutrition prevails, our 
findings indicate that African migrants and refugees gain 
weight rapidly following migration which is consistent 
with the current literature.6,7 We found a prevalence of 
overweight or obesity, measured by BMI, of 62% amongst 
our sample. This figure is slightly higher compared to the 
prevalence of overweight and obesity among Australian 
adults (59.8%) reported in the most recent National 
Health Survey.40 However, there was a significant gender 
differential between our sample and Australian data, with 
the prevalence of overweight or obesity higher among 
SSA women than Australian women (85.7% vs. 52.1%) 
but lower among SSA men than their Australian counter-
parts (54.8% vs. 67.5%). Sub-Saharan African migrants 
and refugees in our study had a lower prevalence of dia-
betes (2.0% vs.7.5%) but a higher prevalence of impaired 
fasting glucose (13.8% vs. 5.7%) than their Australian 
counterparts than that reported in the AusDiab.41 We 
found that 25% of participants had LDL-C levels ≥3.5 
mmol/l and 25% had HDL-C levels <1.03 mmol/L, cut-
off points used to predict heightened risk for heart disease. 
Ridker,42 argues that hs-CRP test along with the lipid 
profile constitutes the best predictor of the risk for car-
diovascular diseases. Using a sample of 27,939 healthy 
women; the author found that hs-CRP is a stronger pre-
dictor of risk than LDL-C, predicts increased risk in sub-
jects without overt hyperlipidemia, and improves prog-
nostic information to risk scoring.42 
 
Policy implications 
The observed prevalence of vitamin D insufficiency in this 
sub-population leads to concerns which warrant increased 
screening efforts and intervention. These findings also sup-
port further work in this area with a much larger, ethnically 
diverse sample, which would include children and other 
migrant groups with darker skin pigmentation. Further 
studies may be needed to examine the relationship be-
tween VDI and the risk of diabetes and cardiovascular 
risk markers among this sub-population. Given the evi-
dence for a beneficial effect of vitamin D in reducing the 
risk of autoimmune diseases, infections, multiple sclero-
sis, high blood pressure, T2D, and cardiovascular dis-
eases,43,44 it is possible that public health interventions 
geared toward early identification and treatment on VDI 
as well as those incorporating vitamin D supplementation, 
or safe sun exposure to maintain serum 25-OHD levels 
through healthy lifestyle interventions could significantly 
reduce the health burden of disease and lead to significant 
health and economic gains. Increasing vitamin D through 
healthy lifestyles could include activities such as walking 
groups in the summer, but care would need to be exer-
cised to minimise the risk of skin cancer. Food fortifica-
tion with vitamin D could also be useful in raising serum 
25-OHD. However, these interventions are unlikely to be 
sufficient to maintain serum 25-OHD levels throughout 
the year in this group. Governments accepting large num-
bers of African migrants need to have migration and 
health policies to inform health programs catering for the 
health of this sub-populations post-migration, and should 
consider building primary prevention strategies such as 
public education into the pre-departure medical assess-
ment and on-arrival information package. 
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澳洲墨爾本之非洲移民及難民的維生素 D不足與第 2型
糖尿病及心血管疾病風險的盛行率 
 
遷移至工業化國家後，撒哈拉沙漠以南之非洲移民及難民，發生第 2 型糖尿病
之風險可謂雪上加霜。這些族群不單是肥胖及第 2 型糖尿病風險增高，更可能
由於維生素 D 不足而更惡化。因此，本篇研究目的在描述澳洲墨爾本 20 歲以
上之非洲移民及難民，維生素 D不足、肥胖與第 2型糖尿病危險因子之人口學
變項。資料蒐集自問卷、醫療評估及禁食血液樣本等。結果發現，49 位研究對
象之血清平均 25-羥基維生素 D 濃度為 27.3 nmol/L (95% CI: 22.2, 32.4 
nmol/L)，其中 88%之參予者 25-羥基維生素 D濃度小於 <50 nmol/L。另外也發
現研究對象，有第 2 型糖尿病與心血管疾病風險因子的集群現象：研究對象
62% 過重或肥胖、47% 有胰島素抗性(HOMA-IR ≥2)、25% 低密度脂蛋白過高
(≥3.5 mmol/L)、24.5% 高密度脂蛋白過低(<1.03 mmol/L)、34.6% 總膽固醇過高
(≥5.2 mmol/L)、18.2% 三酸甘油脂過高(≥1.7 mmol/L)、16% 患有高血壓。本篇
研究顯示，此族群可能處於第 2 型糖尿病與心血管相關疾病風險下，如缺血性
心臟病、中風及周邊動脈疾病等。目前急需進行良好規劃的維生素 D 介入並涵
蓋生活型態改變的方案。 
 
關鍵字：維生素 D不足、空腹血糖、非洲移民及難民、胰島素抗性、肥胖 
